Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» CAP-1002
CAP-1002
Duchenne muscular dystrophy: major trials and events to watch in 2023
Duchenne muscular dystrophy: major trials and events to watch in 2023
Clinical Trials Arena
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
Sarepta Therapeutics
SRP-9001
FibroGen
pamrevlumab
Capricor
CAP-1002
Santhera
ReveraGen
vamorolone
Flag link:
Capricor's DMD clinical trial meets primary endpoints
Capricor's DMD clinical trial meets primary endpoints
Endpoints
Capricor
clinical trials
Duchenne Muscular Dystrophy
CAP-1002
Flag link:
One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
Endpoints
Capricor
stem cells
Duchenne Muscular Dystrophy
CAP-1002
Flag link:
Capricor: Can A Scarred Heart Be Repaired?
Capricor: Can A Scarred Heart Be Repaired?
Seeking Alpha
heart attacks
devices
CAP-1002
Capricor
Flag link:
Capricor gets $12.5M upfront payment in Janssen development agreement
Capricor gets $12.5M upfront payment in Janssen development agreement
Yahoo/Fly on the Wall
Capricor
Janssen
CAP-1002
Flag link:
